Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (161-170 of 286) with videos related to

Pageof 29
Sort By:
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood|October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotypeEllen Leich, Alberto Zamo, Heike Horn, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Science Immunology|June 7, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19Mark Roschewski, Michail S Lionakis, Jeff P Sharman, et al.
Blood|February 1, 2003
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphomaDolors Sanchez-Izquierdo, Gerard Buchonnet, Reiner Siebert, et al.
Blood|July 30, 2005
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genesFanny Rubio-Moscardo, David Blesa, Cinta Mestre, et al.
Leukemia & Lymphoma|October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression statusSamantha Kendrick, Katalin Tus, George Wright, et al.
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.
Blood|January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformationDerville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signatureItziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Pageof 29

Showing results (161-170 of 286) with videos related to

Sort By:
Pageof 29
Blood|July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survivalDerville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood|October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotypeEllen Leich, Alberto Zamo, Heike Horn, et al.
Blood|June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphomaMichael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
Science Immunology|June 7, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19Mark Roschewski, Michail S Lionakis, Jeff P Sharman, et al.
Blood|February 1, 2003
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphomaDolors Sanchez-Izquierdo, Gerard Buchonnet, Reiner Siebert, et al.
Blood|July 30, 2005
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genesFanny Rubio-Moscardo, David Blesa, Cinta Mestre, et al.
Leukemia & Lymphoma|October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression statusSamantha Kendrick, Katalin Tus, George Wright, et al.
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.
Blood|January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformationDerville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signatureItziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Pageof 29